Optimal use of lenvatinib in the treatment of advanced thyroid cancer

por Takahashi, Shunji, Kiyota, Naomi, Tahara, Makoto
Publicado 2017

Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib

por Otsuka, Haruhiko, Fukumoto, Takeshi, Kiyota, Naomi, Takemori, Chihiro, Jimbo, Haruki, Nishigori, Chikako
Publicado 2022

Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance

por Tahara, Makoto, Kiyota, Naomi, Nibu, Ken-ichi, Akamatsu, Ayumi, Hoshino, Tomohiro, Hayashi, Ryuichi
Publicado 2021

Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients

por Fujiwara, Yutaka, Kiyota, Naomi, Chayahara, Naoko, Suzuki, Akiyuki, Umeyama, Yoshiko, Mukohara, Toru, Minami, Hironobu
Publicado 2011

Effects of Aprepitant on the Pharmacokinetics of Controlled-Release Oral Oxycodone in Cancer Patients

por Fujiwara, Yutaka, Toyoda, Masanori, Chayahara, Naoko, Kiyota, Naomi, Shimada, Takanobu, Imamura, Yoshinori, Mukohara, Toru, Minami, Hironobu
Publicado 2014

Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan

por Takahashi, Shunji, Tahara, Makoto, Ito, Koichi, Tori, Masayuki, Kiyota, Naomi, Yoshida, Katsutoshi, Sakata, Yukinori, Yoshida, Akira
Publicado 2020

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge

por Nose, Taku, Funakoshi, Yohei, Suto, Hirotaka, Nagatani, Yoshiaki, Imamura, Yoshinori, Toyoda, Masanori, Kiyota, Naomi, Minami, Hironobu
Publicado 2022

Device-related Mycobacterium mageritense Infection in a Patient Treated with Nivolumab for Metastatic Breast Cancer

por Koyama, Taiji, Funakoshi, Yohei, Imamura, Yoshinori, Nishimura, Sho, Fujishima, Yoshimi, Toyoda, Masanori, Kiyota, Naomi, Tanino, Hirokazu, Minami, Hironobu
Publicado 2021

Radiotherapy for Stage I or II hypopharyngeal carcinoma

por Nishimura, Hideki, Sasaki, Ryohei, Yoshida, Kenji, Miyawaki, Daisuke, Okamoto, Yoshiaki, Kiyota, Naomi, Saito, Miki, Otsuki, Naoki, Nibu, Ken-ichi
Publicado 2012

Roles of skull base surgery and particle radiotherapy for orbital malignant tumors involving the skull base

por Teshima, Masanori, Shinomiya, Hirotaka, Kimura, Hidehito, Hashikawa, Kazunobu, Kiyota, Naomi, Miyawaki, Daisuke, Sasaki, Ryohei, Kohmura, Eiji, Nibu, Ken‐ichi
Publicado 2021

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

por Szturz, Petr, Wouters, Kristien, Kiyota, Naomi, Tahara, Makoto, Prabhash, Kumar, Noronha, Vanita, Adelstein, David, Van Gestel, Dirk, Vermorken, Jan B.
Publicado 2019

[18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy

por Ishihara, Takeaki, Kitajima, Kazuhiro, Suenaga, Yuko, Ejima, Yasuo, Komatsu, Hirokazu, Otsuki,, Naoki, Nibu, Ken-ichi, kiyota, Naomi, Takahashi, Satoru, Sasaki, Ryohei
Publicado 2017

Metabolomics Evaluation of Serum Markers for Cachexia and Their Intra-Day Variation in Patients with Advanced Pancreatic Cancer

por Fujiwara, Yutaka, Kobayashi, Takashi, Chayahara, Naoko, Imamura, Yoshinori, Toyoda, Masanori, Kiyota, Naomi, Mukohara, Toru, Nishiumi, Shin, Azuma, Takeshi, Yoshida, Masaru, Minami, Hironobu
Publicado 2014

Mediastinal Germ Cell Tumor Exhibiting a Discrepancy between Tumor Markers and Imaging: A Case Study

por Takenaka, Kei, Mukohara, Toru, Hirai, Chihoko, Funakoshi, Yohei, Nakamura, Yukiko, Chayahara, Naoko, Toyoda, Masanori, Kiyota, Naomi, Itoh, Tomoo, Yokozaki, Hiroshi, Minami, Hironobu
Publicado 2015

A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinom...

por Zenda, Sadamoto, Ota, Yosuke, Kiyota, Naomi, Okano, Susumu, Fujii, Masato, Kitamura, Morimasa, Takahashi, Shunji, Ueda, Tsutomu, Monden, Nobuya, Yamanaka, Takeharu, Tahara, Makoto
Publicado 2019

Pharmacokinetic study of the oral fluorouracil antitumor agent S‐1 in patients with impaired renal function

por Goto, Keiko, Fujiwara, Yutaka, Isobe, Takeshi, Chayahara, Naoko, Kiyota, Naomi, Mukohara, Toru, Tsubata, Yukari, Hotta, Takamasa, Tamura, Kenji, Yamamoto, Noboru, Minami, Hironobu
Publicado 2019

Relationship between PDGFR expression and the response to pazopanib in intimal sarcoma of the pulmonary artery: A case report

por Sai, Satoshi, Imamura, Yoshinori, Kiyota, Naomi, Jimbo, Naoe, Toyoda, Masanori, Funakoshi, Yohei, Chayahara, Naoko, Hyogo, Yasuko, Takenaka, Kei, Suto, Hirotaka, Minami, Hironobu
Publicado 2021

Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report

por Kimbara, Shiro, Imamura, Yoshinori, Yakushijin, Kimikazu, Higashime, Ako, Koyama, Taiji, Fujishima, Yoshimi, Funakoshi, Yohei, Toyoda, Masanori, Kiyota, Naomi, Matsuoka, Hiroshi, Minami, Hironobu
Publicado 2021

Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population

por Shinomiya, Hirotaka, Shinomiya, Hitomi, Kubo, Mie, Saito, Yuki, Yoshida, Masafumi, Ando, Mizuo, Teshima, Masanori, Otsuki, Naoki, Kiyota, Naomi, Sasaki, Ryohei, Nibu, Ken-ichi
Publicado 2017

The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer

por Nishimura, Meiko, Toyoda, Masanori, Takenaka, Kei, Imamura, Yoshinori, Chayahara, Naoko, Kiyota, Naomi, Mukohara, Toru, Kotake, Takeshi, Tsuji, Akihito, Saito, Kosuke, Saito, Yoshiro, Minami, Hironobu
Publicado 2016